Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
48 | INT-48 | Spain | 2005 | HIV1 | CRF02_AG | Plasma | None |
Treatment History
Order | Regimen | Weeks |
1 | None | NA |
Integrase Sequence
INIMajorDRMs | INIMinorDRMs | Polys | UnusualMuts |
K14R, V31I, L63I, I72V, L74I, E96D, L101I, G106GA, T112V, T124A, G134N, I135V, K136T, V201I, T206S, L234I, R269K |
>INT-48| codons 5-269 IDKAQEEHERYHSNWRAMASDFNLPPIVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQID CTHLEGKVIIVAVHVASGYIEAEVIPAETGQDTAYFILKLAARWPVKVIHTDNGSNFTSA TVKAACWWANVTQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHN FKRKGGIGGYSAGERIIDIIASDIQTKELQKQITKIQNFRVYYRDSRDPIWKGPAKLLWK GEGAVVIQDNSDIKVVPRRKAKIIK |
References
Author | Title | Citation |
Garrido, C | Integrase variability and susceptibility to HIV integrase inhibitors: Impact of subtypes, antiretroviral experience and duration of HIV infection. | J Antimicrob Chemother, 2009 |